Cargando…
Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia
OBJECTIVE: The objective of this study was to examine the relationship between patient beliefs about medication use and their likelihood of discontinuing treatment prematurely. Associations of patient beliefs about medication with clinical psychopathology and their life satisfaction were also assess...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779124/ https://www.ncbi.nlm.nih.gov/pubmed/19956443 |
_version_ | 1782174340403429376 |
---|---|
author | Liu-Seifert, Hong Adams, David H Ascher-Svanum, Haya Faries, Douglas E Kinon, Bruce J |
author_facet | Liu-Seifert, Hong Adams, David H Ascher-Svanum, Haya Faries, Douglas E Kinon, Bruce J |
author_sort | Liu-Seifert, Hong |
collection | PubMed |
description | OBJECTIVE: The objective of this study was to examine the relationship between patient beliefs about medication use and their likelihood of discontinuing treatment prematurely. Associations of patient beliefs about medication with clinical psychopathology and their life satisfaction were also assessed. METHODS: This post-hoc analysis used data from a randomized, open label, 1-year trial of antipsychotics in the treatment of patients with schizophrenia or schizoaffective disorders (N = 664). Medication management including dosage adjustment and medication switching was at doctors’ discretion, reflecting naturalistic treatment in usual clinical care settings. Early treatment discontinuation was defined as all-cause study drop out. Patient-reported beliefs about medication were assessed by Rating of Medication Influences (ROMI), degree of clinical psychopathology was measured by Positive and Negative Syndrome Scale (PANSS), and patient quality of life was measured by Lehman Quality of Life Interview (LQLI). RESULTS: Patient perception of medication benefit was the only strong predictor of treatment duration among the 5 underlying dimensions of medication influence. Higher level of perceived beneficial effect of medication was associated with reduced risk of early treatment discontinuation (Hazard ratio = 0.56, 95% Confidence Interval [0.40, 0.79], p = 0.001). Patients with greater beliefs in the beneficial effect of treatment also had better clinical psychopathology outcome and were more satisfied with their quality of life and well-being. CONCLUSION: Understanding the predictors of early treatment discontinuation in the care of schizophrenia patients is important for the development of interventions to improve treatment outcome. Current findings suggest that patient perception of beneficial effect of medication may be a critical factor in achieving treatment persistence and a satisfactory treatment outcome. |
format | Text |
id | pubmed-2779124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27791242009-12-02 Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia Liu-Seifert, Hong Adams, David H Ascher-Svanum, Haya Faries, Douglas E Kinon, Bruce J Patient Prefer Adherence Original Research OBJECTIVE: The objective of this study was to examine the relationship between patient beliefs about medication use and their likelihood of discontinuing treatment prematurely. Associations of patient beliefs about medication with clinical psychopathology and their life satisfaction were also assessed. METHODS: This post-hoc analysis used data from a randomized, open label, 1-year trial of antipsychotics in the treatment of patients with schizophrenia or schizoaffective disorders (N = 664). Medication management including dosage adjustment and medication switching was at doctors’ discretion, reflecting naturalistic treatment in usual clinical care settings. Early treatment discontinuation was defined as all-cause study drop out. Patient-reported beliefs about medication were assessed by Rating of Medication Influences (ROMI), degree of clinical psychopathology was measured by Positive and Negative Syndrome Scale (PANSS), and patient quality of life was measured by Lehman Quality of Life Interview (LQLI). RESULTS: Patient perception of medication benefit was the only strong predictor of treatment duration among the 5 underlying dimensions of medication influence. Higher level of perceived beneficial effect of medication was associated with reduced risk of early treatment discontinuation (Hazard ratio = 0.56, 95% Confidence Interval [0.40, 0.79], p = 0.001). Patients with greater beliefs in the beneficial effect of treatment also had better clinical psychopathology outcome and were more satisfied with their quality of life and well-being. CONCLUSION: Understanding the predictors of early treatment discontinuation in the care of schizophrenia patients is important for the development of interventions to improve treatment outcome. Current findings suggest that patient perception of beneficial effect of medication may be a critical factor in achieving treatment persistence and a satisfactory treatment outcome. Dove Medical Press 2007-12-20 /pmc/articles/PMC2779124/ /pubmed/19956443 Text en © 2007 Liu-Seifert et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Liu-Seifert, Hong Adams, David H Ascher-Svanum, Haya Faries, Douglas E Kinon, Bruce J Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia |
title | Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia |
title_full | Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia |
title_fullStr | Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia |
title_full_unstemmed | Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia |
title_short | Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia |
title_sort | patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779124/ https://www.ncbi.nlm.nih.gov/pubmed/19956443 |
work_keys_str_mv | AT liuseiferthong patientperceptionofmedicationbenefitandearlytreatmentdiscontinuationina1yearstudyofpatientswithschizophrenia AT adamsdavidh patientperceptionofmedicationbenefitandearlytreatmentdiscontinuationina1yearstudyofpatientswithschizophrenia AT aschersvanumhaya patientperceptionofmedicationbenefitandearlytreatmentdiscontinuationina1yearstudyofpatientswithschizophrenia AT fariesdouglase patientperceptionofmedicationbenefitandearlytreatmentdiscontinuationina1yearstudyofpatientswithschizophrenia AT kinonbrucej patientperceptionofmedicationbenefitandearlytreatmentdiscontinuationina1yearstudyofpatientswithschizophrenia |